Patient-Funded Cancer Research
Oldham, Robert K.
New England Journal of Medicine. 1987 Jan 1; 316(1): 46-47.
The author, a physician associated with the Biological Therapy Institute in Franklin, Tennessee, defends the rise of privately-funded cancer research facilities that seek to develop biological treatment tailored to individual patient needs. He rejects charges that lack of equal access is unique to these facilities and that objective, informed consent cannot be given for self-funded research. Oldham contends that the successful development of biotherapy by privately-funded research will benefit patients unresponsive to other treatments, provide a new source of funding for cancer research, hasten the determination of the technical feasibility and clinical efficacy of biological approaches to cancer therapy, and lead to biotherapy's acceptance as reimbursable by insurance companies. (KIE abstract)
Biomedical Research; Cancer; Conflict of Interest; Consent; Drugs; Economics; Financial Support; Health; Health Insurance; Hospitals; Human Experimentation; Industry; Informed Consent; Insurance; Patients; Proprietary Hospitals; Remuneration; Research; Research Institutes; Research Subjects; Risks and Benefits; Social Impact; Therapeutic Research;
Showing items related by title, author, creator and subject.
Garrett, Robert E.; Sutter, M.C.; Havranek, Edward P.; Oldham, Robert K. (1987-07-16)
Oldham, Robert K. (1987-01-01)
Morreim, E. Haavi (1991-05)